Data as of Apr 17
| +0.08 / +5.16%|
The 6 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 3.25, with a high estimate of 4.00 and a low estimate of 1.00. The median estimate represents a +99.39% increase from the last price of 1.63.
The current consensus among 9 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.